Semax and selank on TikTok: hype vs. actual human data

What did @gettinlippywithbrit2.0 actually say?

The creator described two weeks of using semax and selank together and reported feeling "calm," "focused," and sleeping without anxiety. Before starting, she says she had "constant brain fog, constant overthinking" and couldn't multitask. After two weeks, she calls these peptides her favorites of everything she's tried and signs off that she's "sharp as a tick."

To be clear about what's happening here: this is a personal anecdote from someone promoting a telehealth platform's free consultation service. The video isn't framed as a clinical report. But because it's reaching tens of thousands of viewers who may be searching for solutions to real anxiety and cognitive complaints, the claims deserve scrutiny regardless of how casually they're delivered. She's not lying about her experience. The problem is what she's implying about why it happened.

Does the science back this up?

Partially, but the human evidence is thin and the mechanisms are more complicated than a two-week TikTok suggests. Most of the credible research on these peptides comes from Russian clinical settings, and neither compound has FDA approval for any indication.

Selank is a synthetic analog of tuftsin with anxiolytic properties studied primarily in Russia. A 2014 study by Zozulya et al. published in CNS Drug Reviews found selank produced anxiety-reducing effects in patients with generalized anxiety disorder with fewer sedative side effects than benzodiazepines in small-scale trials. That's genuinely interesting. But those were controlled studies with defined populations, not people stacking peptides they sourced through a telehealth app. Semax, a synthetic ACTH analog, has shown neuroprotective and cognitive-enhancing effects in animal models and some small Russian stroke-rehabilitation trials. A 2002 study by Ashmarin et al. in the journal Neuroscience and Behavioral Physiology described improvements in attention and memory in healthy subjects. Again, real findings, but small samples, no long-term safety data, and largely unreplicated in Western peer-reviewed journals.

The combination of both peptides simultaneously has essentially no controlled human trial data.

What did they get wrong (or right)?

She got the general pharmacological direction right. Selank does appear to have genuine anxiolytic activity, and semax does appear to modulate dopaminergic and serotonergic systems in ways that could plausibly affect focus. Saying she feels calmer and more focused on these compounds isn't inherently implausible based on what we know about their mechanisms.

What she got wrong is framing a two-week subjective experience as meaningful evidence of anything. "It's only week two" is the most honest thing she says, and then she immediately undermines it by calling them possibly her favorite peptides ever. Two weeks is not enough time to distinguish a pharmacological effect from placebo, expectation bias, or natural fluctuation in anxiety levels. People with anxiety disorders frequently have good weeks that have nothing to do with any intervention.

She also doesn't mention dose, route of administration, or where she sourced these compounds. That's not a minor omission. Peptide purity in the unregulated supplement and compounding market varies significantly, and without knowing what's actually in the product she's using, attributing any effect to semax or selank specifically is a logical leap.

What should you actually know?

If you're dealing with chronic brain fog, anxiety, or sleep disruption, you should know that both of these peptides exist in a regulatory gray zone in the United States. Neither is FDA-approved. They are not available as prescription drugs in standard U.S. pharmacies. Some compounding pharmacies produce them, but quality and concentration are not standardized.

The mechanism behind selank's apparent anxiolytic effect involves modulation of GABA receptor sensitivity and possible effects on BDNF expression, according to research by Pavlov et al. (2015, Bulletin of Experimental Biology and Medicine). Semax appears to increase BDNF and influence dopamine metabolism, which could plausibly support focus and mood stability. These are real biological targets. But "real targets" and "proven clinical outcomes in healthy people after two weeks" are not the same sentence.

Anyone considering these compounds should be working with a licensed clinician who can review their full health history, not making decisions based on a TikTok where someone says they're "sharp as a tick." A free consultation through a platform advertised in a peptide influencer video is a starting point for a sales conversation, not a substitute for individualized medical assessment.